Early Access — free while we kick the tires
EdgarHawk

WIGGANS THOMAS G

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-24

Companies

Company Buys Sells Direction
Jasper Therapeutics, Inc. JSPR 1 0 Net buying

Activity

September 2025
high
Buy
41,000 shares
$99,630
Significance 7/10

Director WIGGANS THOMAS G bought 41,000 shares of JSPR at $2.43; stock down -90.6% from 52-week high amid 3 other insider buys in 14 days.

Director Wiggans purchased 41,000 shares at $2.43, establishing an initial position, while the stock trades at $2.33 — down -90.6% from its 52-week high of $24.73 and -59.0% over the past 90 days. The timing comes during a cluster of 4 insider buys within 14 days, suggesting coordinated appetite despite the company's $-26.7M net loss and $37.9M market cap. Wiggans' cross-ticker track record shows 100% win rate on prior buys with avg 90d return of +2923.1%; his prior 5 trades at JSPR each posted triple-digit 90-day gains (range +2830.4% to +3106.9%), all well-timed. The current purchase occurs at depressed absolute price levels after a steep drawdown, but the unprofitable fundamentals and heavy capital losses relative to market cap distinguish this setup from his prior profitable entries.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access